Low fractional exhaled nitric oxide (FeNO) levels have been described as markers of comorbid bronchiectasis in asthma [4] and infectious exacerbations in patients treated with anti-interleukin (IL)-5 antibody for severe asthma [8]. The gene discussed is IL5; the disease is asthma.